Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
Main Authors: | M. Vassallo, J. Durant, R. Fabre, F. DeSalvador, C. Lebrun-Frenay, M. Laffon, M. Ticchioni, J. Cottalorda, P. Dellamonica, C. Pradier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Journal of Virus Eradication |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020313881 |
Similar Items
-
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)
by: Marie-Lise Gougeon, et al.
Published: (2017-02-01) -
Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)’
by: Marie-Lise Gougeon, et al.
Published: (2017-03-01) -
Active hepatitis C is associated with a larger HIV reservoir in successfully treated patients
by: Matteo Vassallo, et al.
Published: (2018-05-01) -
The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review
by: Vassallo Matteo, et al.
Published: (2012-08-01) -
Attention and Neurocognitive Impairment in ADHD
by: J Gordon Millichap
Published: (2007-07-01)